4

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: November 30, 2018
Period of Report: November 30, 2018
Accession Number: 0001144204-18-062654

View Document ↗ View on SEC.gov ↗